DAV Launches Digital Resource on Psychedelic Therapy for Veterans

ERLANGER, Ky. – DAV (Disabled American Veterans) has launched an online resource on psychedelic-assisted therapies for service-related mental health conditions.

A growing number of veterans seek alternative treatments after exhausting traditional options. Meanwhile, clinical researchers are advancing studies of plant medicines—like psilocybin, ibogaine, and MDMA—at a time when legal access in the United States remains limited. As a result, many veterans travel abroad—often at significant personal risk and cost—to pursue these treatments.

DAV champions continued rigorous research into psychedelic-assisted therapies while stressing the importance of safety, oversight, and evidence-based care. This new resource gives veterans, policymakers, and the public clear, balanced information on this emerging issue.

“Veterans are not looking for a good time with psychedelics—they’re looking for healing,” said DAV National Adjutant Barry Jesinoski. “Our goal is to provide clear, credible information so everyone involved can understand the science, the risks and what it means for their care.”

Mindscapes is available now, as part of DAV’s broader work exploring innovative approaches to veteran mental health.

About DAV

DAV empowers veterans to lead high-quality lives with respect and dignity. It is dedicated to a single purpose: keeping our promise to America’s veterans. DAV does this by ensuring that veterans and their families can access the full range of benefits available to them, fighting for the interests of America’s injured heroes on Capitol Hill, providing employment resources to veterans and their families, and educating the public about the great sacrifices and needs of veterans transitioning back to civilian life. DAV, a nonprofit organization with nearly 1 million members, was founded in 1920 and chartered by the U.S. Congress in 1932.